STILL NOT FREE
Brittney Griner will remain detained in Russia until at least July 2
WNBA player Brittney Griner’s detention in Russia has been extended until at least July 2, according to Russian state news, per CNN.
The player is alleged to have been carrying vape cartridges containing cannabis in an airport near Moscow while travelling back to the USA from Russia. She has been detained since February
“Her detention is inhumane and unacceptable,” said Griner’s agent Lindsay Kagawa Colas. “She has not had a single phone call in her 117 days of wrongful detention.” Colas called on President Biden and VP Kamala Harris to “act with urgency and do whatever it takes to bring Brittney home immediately.”
WIN FOR MACE
Nancy Mace, who was attacked for her cannabis reform bill, wins SC primary
Republican Nancy Mace, the sponsor of the States Reform Act, won the primary in South Carolina. She defeated Katie Arrington, who was endorsed by former president Trump, reports The State.
Arrington’s campaign took aim at Mace’s efforts to legalize cannabis, demanding Mace take a drug test and even asking, “Is Nancy Mace high?” in a campaign ad. Trump, who Mace criticized after the Jan. 6, 2021 Capitol insurrection, called her an “absolutely terrible candidate.”
“It is not easy to put yourself out there, to put yourself in public, to put it all on the line and take that risk,” said Mace, who won by 7 percentage points. “I want to thank her for her passion.”
AU NATUREL
Oregon will be the first state to ban synthetic cannabinoids in unlicensed stores
Starting July 1, Oregon’s ban on synthetic cannabinoids in shops without a special licence such as grocery stores will come into force, per Oregon Live. It will be the first state to do so.
In Oregon, synthetic non-THC cannabinoids like CBN and delta-8 THC are largely unregulated.
After a one year grace period, all products containing synthetic cannabinoids will have to be sold in Oregon Liquor and Cannabis Commission-licensed retailers.
STOCK DROP
Why Bright Green’s stock price has dropped 89% in the last year
Florida-based Bright Green Corp. was once valued at USD $9 billion with a stock price reaching $60/share, but investors may have failed to catch a few key issues with the company, which said it was close to being approved by the DEA to grow cannabis for research purposes, per MJBizDaily. Now, it’s trading around USD $2.71.
According to Bright Green’s regulatory filings and financials:
- It does not yet have DEA approval to provide cannabis to researchers
- There are barriers to raising USD $300 million to build a medical cannabis research, cultivation and production facility in Grants, New Mexico
- The company hasn’t made a sale
“We can provide no assurance that we will generate sufficient revenues from our intended business operations to sustain a viable business operation,” Bright Green warned in its filings. “In order to generate revenues, we must first receive receipt of final registration from the DEA.”
Read the full article here
